# crcns-ret-1 · claims-check · run 39473947251

Model `claude-opus-5-5`, Claude Code 2.1.284, permission mode `default`. Tools: `Task`, `Bash`, `DesignSync`, `Edit`, `EnterWorktree`, `ExitWorktree`, `Glob`, `Grep`, `ListAgents`, `NotebookEdit`, `Read`, `ReportFindings`, `SendMessage`, `Skill`, `TaskCreate`, `TaskGet`, `TaskList`, `TaskStop`, `TaskUpdate`, `ToolSearch`, `WebFetch`, `WebSearch`, `Write`.

**Agent calls Bash**

```bash
ls claims/crcns-ret-1/ paper/; grep -n "Reader" -A60 docs/protocol.md | head -120
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
sed -n 96,200p docs/protocol.md
```

```
- `expected`: each reported number the claim rests on, with a tolerance.
     Use the paper's own uncertainty when it gives one (a confidence
     interval, or the stated spread); otherwise 10% of the reported value.
     For a reported range ("2 to 13%"), the claim holds inside the range
     widened by 10% of each bound. Give the reason for any other tolerance.
   - `criterion`: how the claim will be judged, for any claim that is not
     settled by its expected values alone ("similar", "many", "tended to").
     It is written from the paper alone, before anyone analyses the data.
   - When a reported number can be read in more than one way (which trials
     form the denominator, which subset is meant), list in the criterion the
     readings the paper's text plausibly allows, before the analysis. The
     claim is reproduced if the result matches under any of them. The
     notebook shows every reading, the notes say which ones match, and the
     ambiguity is recorded as a deviation.
   - Methods come from the paper, never from the author. Every part of a
     criterion's method (the selection, the measure, the test, windows,
     bins, thresholds, what a measure is compared with) is taken from the
     Methods, the figure legends, the supplement, or the code the paper
     links, and the criterion says which. Search all of them before
     treating a detail as open.
[... 85 more lines not kept]
```

**Agent calls Bash**

```bash
cat claims/crcns-ret-1/10.1242-dev.027912.yaml; python tools/claims_check.py claims/crcns-ret-1/10.1242-dev.027912.yaml paper/10.1242-dev.027912.txt
```

Result: not kept, because it reads the paper's text.

**Agent calls Read**

```json
{
 "file_path": "/home/runner/.claude/projects/-home-runner-work-reproduction-registry-reproduction-registry/b87e17a1-4e22-4e08-bc8d-1c3b0a8c51e1/tool-results/bcf84bwe0.txt"
}
```

```
1	# Claims for Lefebvre, Zhang, Meister, Wang & Sanes (2008), Development 135:4141-4151, on CRCNS
2	# data set ret-1 (doi:10.6080/K0RF5RZT).
3	# Written by an agent (model "claude-opus-5-5", Claude Code in GitHub Actions), 2026-10-20,
4	# protocol pilot-10 as stated in docs/protocol.md (Reader).
5	#
6	# Text read: the NIH author manuscript in PubMed Central (PMC2644426), as supplied under paper/,
7	# with its Methods, Results, Discussion and the legends of Figures 1 to 9; the version of
8	# record's abstract is appended to it. No PDF was supplied. The supplement (Supplementary
9	# Figures 1 to 3, which PMC lists as present) is not in the text and was not read. It holds
10	# figures only, not methods: the Chx10-Cre recombination pattern (S1), synapse density in Bax
11	# mutants and example spike-triggered averages (S2; the manuscript cites S2 for both), and
12	# receptive field surrounds (S3). The claims that cite it are quoted from the main text and
13	# take no number from it. The paper links no analysis code, so none was read.
14	#
15	# Data the paper used. Mice on a C57/B6J background. Conditional Pcdh-gamma alleles (fdel, the
16	# whole cluster floxed; fcon3, the last constant exon floxed), excised in retina by Chx10-Cre
17	# or Pax6alpha-Cre (Pax6alpha-Cre spares a central sector except for Pax6alpha amacrines); some
18	# crossed onto Bax-/-. Histology (Figures 1 to 8): sections and dissociated cells, layer
19	# thickness and cell counts at E17.5 to P150, 3 to 8 animals per genotype; none of it is in
20	# the data set. Electrophysiology (Figure 9), the data the CRCNS data set describes holding:
[... 461 more lines not kept]
```

**Agent calls Bash**

```bash
wc -c paper/*.txt; cat paper/10.1242-dev.027912.txt
```

Result: not kept, because it reads the paper's text.

**Agent calls Bash**

```bash
fold -w 3000 -s paper/10.1242-dev.027912.txt | head -c 40000
```

Result: not kept, because it reads the paper's text.

**Agent**

The checker reports 0 problems on 26 claims. Now reading the paper itself to check each claim.

**Agent calls Bash**

```bash
fold -w 200 -s paper/10.1242-dev.027912.txt > $TMPDIR/p.txt; wc -l $TMPDIR/p.txt; echo $TMPDIR
```

Result: not kept, because it reads the paper's text.

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt"
}
```

```
1	DOI: 10.1242/dev.027912
2	Version: author manuscript, PMC2644426
3	Source: ncbi_pmc+crossref (paper-text-fetcher)
4	Stored: 2026-10-20
5	Extracted: as fetched
6	------------------------------------------------------------------------
7	Development 319 nihpa 8701744 Development (Cambridge, England) 0950-1991 1477-9129 pmc-is-collection-domain yes pmc-collection-title NIHPA Author Manuscripts PMC2644426 PMC2644426.1 2644426 2644426 
8	NIHMS88650 19029044 10.1242/dev.027912 NIHMS88650 NIHPA88650 1 Article GAMMA PROTOCADHERINS REGULATE NEURONAL SURVIVAL BUT ARE DISPENSABLE FOR CIRCUIT FORMATION IN RETINA Lefebvre Julie L. 1 Zhang 
9	Yifeng 1 Meister Markus 1 Wang Xiaozhong 2 Sanes Joshua R. 1 1 Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138, USA 2 Department of 
10	Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston IL 60208, USA For correspondence: Joshua R. Sanes Department of Molecular and Cellular Biology Harvard University 
11	Cambridge MA 02138 Phone: 617-496-8683 email: [removed: an e-mail address] 12 2008 135 24 176754 4141 4151 27 01 2009 01 06 2009 01 06 2009 19 09 2026 This file is available for text mining. It may also be 
12	used consistent with the principles of fair use under the copyright law. SUMMARY Twenty-two tandemly arranged protocadherin-γ (Pcdh-γ) genes encode transmembrane proteins with distinct 
13	cadherin-related extracellular domains and a common intracellular domain. Genetic studies have implicated Pcdh-γs in regulation of neuronal survival and synapse formation. Because mice lacking the 
14	Pcdh-γ cluster die perinatally, we generated conditional mutants to analyze roles of Pcdh-γs in the development and function of neural circuits. Retina-specific deletion of Pcdh-γs led to 
15	accentuation of naturally occurring death of interneurons and retinal ganglion cells (RGCs) during the first two postnatal weeks. Nonetheless, many neuronal subtypes form
[... 195 more lines not kept]
```

**Agent calls Bash**

```bash
grep -n -i "figure 4\.\|figure 5\.\|figure 6\.\|figure 8\.\|figure 9\.\|legend\|FIGURE\|Supplementary\|Table" $TMPDIR/p.txt | sed -n 1,80p | cut -c1-200
```

```
43:fusg vector shown in Figure 2B of Wang et al (2002) by inserting a loxP sequence into an NheI site upstream of the final coding exon. The Pcdh-γ fdel allele was generated by re-targeting the ES cel
64:stimulus intensity at location x and time t , with the time-averaged intensity subtracted, and the neuron fired a total of n spikes at times { t j }. Examples are shown in Supplemental Figure 2 . W
66:temporal components analyzed in Figure 9 . For analysis of response threshold and gain, we fitted the time-dependent RGC firing rate r ( t ) by a Linear-Nonlinear model ( Chichilnisky, 2001 ), (3) 
71:of three cellular layers separated by two synaptic or “plexiform” layers ( Figure 1A ). The cellular layers are the outer nuclear layer (ONL), containing photoreceptors; the inner nuclear layer 
74:of GFP in Pcdh-γ fusg mice, Pcdh-γs are present in all five retinal layers ( Figure 1A ). In the ONL, Pcdh-γs are present in outer segments and around photoreceptor somata ( Figure 1B ); in the INL
75:and GCL, Pcdh-γs outline neuronal somata ( Figure 1C,D ). Pcdh-γ levels are highest in the most membrane-rich layers—IPL, OPL, and the optic fiber layers that carry RGC axons to the brain ( Figure 
76:1A′,D ). In situ hybridization confirmed Pcdh-γ expression by cells in the INL and GCL, though this method did not reliably detect Pcdh-γ RNA in photoreceptors ( Figure 1E ). To determine which 
80:Müller glia. All six cell types were Pcdh-γ-positive ( Figures 1F-K and data not shown). Thus, Pcdh-γs are expressed in all cell types of the neural retina. We asked whether Pcdh-γs are present in 
83:IPL, and on RGC axons ( Figure 2A ). At P3, Pcdh-γ is apparent in the layer of horizontal cells that prefigures the OPL ( Figure 2B ). By P7, Pcdh-γ appears in the OPL, as it divides the neuroblast
84:layer into INL and ONL ( Figure 2C ). By P14, the adult pattern described above is established ( Figure 2D ). Synaptic localization of Pcdh-γ proteins in the retina To evaluate the subcellular 

[... 46 more lines not kept]
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "offset": 210,
 "limit": 8
}
```

```
210	packed, so we could not determine their number accurately. Given the electrophysiological evidence for maintained synaptic function, however, it seems unlikely that any synaptic defect is sufficient 
211	in magnitude to explain the massive apoptosis we observe. Likewise, synaptic patterns in the IPL of Pcdh–γ mutants are at least as well preserved in the absence of Bax as in its presence, ruling out 
212	the possibility that apoptosis reflects selective elimination of inappropriate synapses. Thus, synapses can be lost in the absence of neuronal loss in the spinal cord, and neurons can be lost in the 
213	absence of major synaptic defects in retina. These results suggest that Pcdh–γ regulates neuronal survival and synaptic maturation by distinct mechanisms, and that effects on these two processes 
214	differ in severity among brain regions. The combinatorial diversity provided by the Pcdh–γ may therefore be useful for selectively controlling the size of diverse neuronal populations. Supplementary 
215	Material Supp ACKNOWLEDGMENTS We thank Joshua Weiner for sharing data. This work was supported by grants from the National Institutes of Health to M.M. and J.R.S, a NARSAD Young Investigator award to 
216	J.L., and Damon Runyons Cancer Research Foundation Fellowship to Y-F.Z. REFERENCES Benson DL Colman DR Huntley GW Molecules, maps and synapse specificity Nat Rev Neurosci 2001 2 899 909 11733797 
217	10.1038/35104078 Blanks JC Hageman GS Johnson LV Appearance of PNA-binding cells within the outer nuclear layer coinciding with photoreceptor degeneration in rd mice Prog Clin Biol Res 1987 247 229
```

**Agent calls Read**

```json
{
 "file_path": "/tmp/claude-1001/p.txt",
 "offset": 269,
 "limit": 70
}
```

```
269	10.1016/j.neuroscience.2006.10.011 Figures Figure 1 Pcdh-γs are broadly expressed in the retina (A-D) Retinas from pcdh-γ fusg/fusg mice, expressing a Pcdh-γ-GFP fusion, were stained with antibody to 
270	GFP (green in A) and DAPI (blue in A). Pcdh-γ–GFP fusion proteins are concentrated in the process-rich outer plexiform layer (OPL), inner plexiform layer (IPL) and retinal fiber layer (arrow) as well 
271	as in outer segments (OS) of photoreceptors, outer and inner nuclear layers (ONL, INL) and ganglion cell layer (GCL). B-D show high magnification images of areas labeled in A'. (E) In situ 
272	hybridization to P21 retina using a probe against the Pcdh-γ common intracellular domain. (F-K). Dissociated Pcdh-γ fusg/fusg retinal cells immunolabeled with cell-type specific antibodies (red) and 
273	anti-GFP (green). Pcdh-γ–GFP-positive cells are labeled with photoreceptor (PR) marker recoverin, horizontal cell (HZ) marker calbindin, amacrine (AC) marker syntaxin, RGC marker Brn3a, and Müller 
274	Glia (MG) markers glutamine synthetase (H) and Sox9 (K). Scale bar: A, E, 50 μm; B-D, 10 μm. Figure 2 Pcdh-γs localize to retinal plexiform layers during postnatal development (A-D) Immunolabeling of 
275	Pcdh-γ fusg/fusg retina at P0 (A), P3 (B), P7 (C), and P14 (D), with GFP antibody. At P0 and P3, Pcdh-γ-GFP proteins are present in the IPL and retinal axon layer (arrow), and are distributed around 
276	cell somata in the neuroblast layer (NBL; other abbreviations as in Figure 1 ). At P3, Pcdh-γs are also present in presumptive horizontal cells (asterisk; inset in B). By P7, Pcdh-γ-GFPs are detected 
277	in the emerging OPL, as it develops between the ONL and INL. By P14, the adult pattern of Pcdh-γ-GFP localization (see Figure 1 ) is attained. Scale bar, 20 μm; 10 μm in inset. Figure 3 Subcellular 
278	localization of Pcdh-γs in the synaptic plexiform layers (A-E) Confocal images of the OPL of Pcdh-γ fusg/fusg retinas double labeled with anti-GFP (green) and antibodies
[... 60 more lines not kept]
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "# Figures 1 to 3, which PMC lists as present) is not in the text and was not read. It holds\n# figures only, not methods: the Chx10-Cre recombination pattern (S1), synapse density in Bax\n# mutants and example spike-triggered averages (S2; the manuscript cites S2 for both), and\n# receptive field surrounds (S3). The claims that cite it are quoted from the main text and\n# take no number from it.",
 "new_string": "# Figures 1 to 3, which PMC lists as present) is not in the text and was not read. Its\n# contents are known only from the main text's citations: the Chx10-Cre recombination pattern\n# (S1), synapse density in Bax mutants and example spike-triggered averages (S2; the\n# manuscript cites S2 for both), and receptive field surrounds (S3). Its legends were not seen\n# and may hold method details (the test of S2, the measure of S3). The claims that cite it are\n# quoted from the main text and take no number from it."
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "the legend says\n    the differences are significant in the NBL at P0 and P7",
 "new_string": "the legend says\n    the differences are significant in the \"NBL/IPL\" (as printed, likely NBL/INL) at P0 and P7"
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "  statistics:\n  - test: Student's t-test or Mann-Whitney test\n    p: 0.0001\n    p_relation: \"<\"\n    n: 6 to 8 animals per genotype\n  expected:\n    quantity: reduction of Pax6alpha-GFP amacrines in central retina\n    value: 58\n    tolerance: 5.8\n    unit: percent\n  criterion: Reproduced when the reduction is within tolerance and significant, and the central\n    and peripheral reductions do not differ significantly by the same tests. The figure's\n    significance marks run from p < 0.05 to p < 0.0001 and the legend does not say which\n    applies to which bar. Not testable on a spike-recording data set.",
 "new_string": "  statistics:\n  - about: Pax6alpha amacrines, central retina, mutant against control; the weakest mark the\n      legend defines, as the text does not say which mark this bar carries\n    test: Student's t-test or Mann-Whitney test\n    p: 0.05\n    p_relation: \"<\"\n    n: 6 to 8 animals per genotype\n  expected:\n  - quantity: reduction of Pax6alpha-GFP amacrines in central retina\n    value: 58\n    tolerance: 5.8\n    unit: percent\n  criterion: Reproduced when the reduction is within tolerance and significant at p < 0.05 by\n    Student's t-test (equal variances by F-test) or Mann-Whitney test (Figure 6F legend,\n    Methods), and the central and peripheral (Figure 4I, AC) reductions do not differ\n    significantly. The paper names no test for the central against peripheral comparison; the\n    same tests at p < 0.05 are used, and this is open. The figure's significance marks run from\n    p < 0.05 to p < 0.0001 and the legend does not say which applies to which bar. Not testable\n    on a spike-recording data set."
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "Reproduced when, under every reading, the mutant group holds cells of\n    each of the three polarities and of both time courses; the class counts per group are\n    reported.",
 "new_string": "Reproduced when, under every reading, the mutant group and the control\n    group each hold cells of each of the three polarities and of both time courses; the class\n    counts per group are reported."
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "ON and ON-OFF are taken from the\n    flash readings of fig9a-response-variety. Reproduced when, under every reading, at least\n    one mutant ON cell and one mutant ON-OFF cell are direction selective. Blocked when the\n    data set holds no moving-grating recordings from mutant retinas.",
 "new_string": "ON and ON-OFF are taken from the\n    flash readings of fig9a-response-variety. The Results also name moving bars (\"moving bars\n    and gratings\", with \"data not shown\"), whose parameters are not given; mutant moving-bar\n    recordings are analysed the same way, per direction. Reproduced when, under every reading,\n    at least one mutant ON cell and one mutant ON-OFF cell are direction selective. Blocked\n    when the data set holds no moving-grating or moving-bar recordings from mutant retinas."
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Edit**

```json
{
 "replace_all": false,
 "file_path": "claims/crcns-ret-1/10.1242-dev.027912.yaml",
 "old_string": "  expected:\n    quantity: reduction of Brn3a+ RGCs in central retina",
 "new_string": "  expected:\n  - quantity: reduction of Brn3a+ RGCs in central retina"
}
```

```
The file claims/crcns-ret-1/10.1242-dev.027912.yaml has been updated successfully.
```

**Agent calls Bash**

```bash
cd claims/crcns-ret-1 && sed -n '/reduction of Brn3a+/,/unit/p' 10.1242-dev.027912.yaml
```

```
- quantity: reduction of Brn3a+ RGCs in central retina
    value: 15
    tolerance: 1.5
    unit: percent
```

**Agent**

Indentation is correct. Adding the checks entry and rerunning the checker.

**Agent calls Bash**

```bash
cd  && grep -n "^checks" claims/crcns-ret-1/*.yaml; cat >> claims/crcns-ret-1/10.1242-dev.027912.yaml <<'EOF'
checks:
- date: 2026-10-20
  kind: agent
  model: claude-opus-5-5
  ready: true
  changes:
  - header, the line saying the supplement holds figures only and no methods is unsupported, as its legends were not read; now says they may hold method details.
  - fig5-increased-apoptosis, the criterion quoted the Figure 5 legend as "NBL"; the legend prints "NBL/IPL", now quoted as printed.
  - fig6f-amacrine-loss-central, p < 0.0001 was not the paper's for this bar, since the legend defines three marks and the text does not say which this bar carries; now p < 0.05, the weakest mark, with a note under about.
  - fig6f-amacrine-loss-central, the criterion now names the tests (Figure 6F legend, Methods) and says that the paper names no test for central against peripheral, which is left open.
  - fig6f-amacrine-loss-central and fig6f-neighbours, expected written as a list like the other claims.
  - fig9a-response-variety, the statement covers mutant and control retinas ("similar variety") but the criterion tested only the mutant group; it now requires both groups to hold every class.
  - fig9b-direction-selective, the Results name moving bars as well as gratings for the direction-selective cells, so moving-bar recordings are now included and the claim is blocked only when neither is present.
  - open, the supplement (Supplementary Figures 1 to 3 and their legends) is not in the text; the test of fig8el-synapse-density and the measure of s3-receptive-field-surrounds may be given there.
  - open, the paper gives no class cut-offs (fig9a), direction selectivity index (fig9b), surround measure (s3), flash response test or intensities (fig9-rod-cone), construction of the 95% bands (fig9c to fig9h) or LN fitting procedure (fig9g, fig9h); the readings named in the criteria are the file's, chosen because the paper fixes none, and outcomes are blocked when they disagree.
  - open, the Results name the mutant allele fcon3 and the Figure 9 legend names f-del; the paper does not settle which.
  - open, fig5-postnatal-onset requires the reductions "do not grow" after P14, from "changed little"; the paper gives no test for this.
EOF
python tools/claims_check.py claims/crcns-ret-1/10.1242-dev.027912.yaml paper/10.1242-dev.027912.txt; git status --short
```

Result: not kept, because it reads the paper's text.

**Agent**

The claims file is ready for an attempt. I edited only `claims/crcns-ret-1/10.1242-dev.027912.yaml`, with nothing committed or pushed.

**Checker:** `claims/crcns-ret-1/10.1242-dev.027912.yaml: 26 claims, 26 quotes, 6 statistical values, 0 problems`. This is the same result before and after my edits.

**Changes, by claim:**
- **Header:** it said the supplement "holds figures only, not methods". Nobody has read the supplement, so that is unsupported. It now says the supplement's legends may hold method details.
- **fig5-increased-apoptosis:** the criterion quoted the Figure 5 legend as "NBL". The legend prints "NBL/IPL", and it is now quoted as printed.
- **fig6f-amacrine-loss-central:**
  - The recorded p < 0.0001 was a guess. The legend defines three significance marks and the text does not say which one this bar carries, so it is now p < 0.05, the weakest mark, with a note explaining why.
  - The criterion now names the tests from the Figure 6F legend and the Methods.
  - It also says the paper gives no test for comparing central against peripheral retina, so that comparison is marked open.
  - `expected` is now a list, like the other claims.
- **fig6f-neighbours:** `expected` is now a list.
- **fig9a-response-variety:** the statement covers mutant and control retinas ("similar variety"), but the criterion only tested the mutant group. It now requires both groups to have every response class.
- **fig9b-direction-selective:** the Results say the retina was probed with "moving bars and gratings", not gratings alone. Moving-bar recordings are now included, and the claim is blocked only when neither kind is in the data set.

No claim ids changed. No main finding lacks a claim, and none comes from outside the paper.

**What remains open:**
- **Supplement:** Supplementary Figures 1 to 3 are not in the text. Their legends may give the test used in fig8el (synapse density) and the surround measure for s3.
- **Figure 9 method details the paper does not give:**
  - cut-offs for the response classes (fig9a)
  - a direction selectivity index (fig9b)
  - the surround measure (s3)
  - the flash intensities and how a response is judged (fig9-rod-cone)
  - how the 95% bands are built (fig9c to fig9h)
  - how the model behind the threshold and gain was fitted (fig9g, fig9h)

  The readings named in those criteria were chosen by the first reader, because the paper fixes none. When the readings disagree, the claim is blocked as underspecified.
- **Mutant allele:** the Results name fcon3 and the Figure 9 legend names f-del. The paper does not say which is right.
- **fig5-postnatal-onset:** the criterion requires that the thinning "does not grow" after P14, from the paper's "changed little". The paper gives no test for this.

## End of run

20 turns, 2 minutes, result: success.
